Prosecution Insights
Last updated: October 01, 2026
Application No. 18/166,228

COMPOSITION FOR REMEDIATING IRON SULFIDE IN OILFIELD PRODUCTION SYSTEMS

Non-Final OA §103
Filed
Feb 08, 2023
Priority
Nov 30, 2016 — provisional 62/428,123 +1 more
Examiner
LI, AIQUN
Art Unit
1766
Tech Center
1700 — Chemical & Materials Engineering
Assignee
ChampionX LLC
OA Round
7 (Non-Final)
64%
Grant Probability
Moderate
7-8
OA Rounds
0m
Est. Remaining
87%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allowance Rate
539 granted / 845 resolved
-1.2% vs TC avg
Strong +23% interview lift
Without
With
+23.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
50 currently pending
Career history
879
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
51.4%
+11.4% vs TC avg
§102
24.0%
-16.0% vs TC avg
§112
17.7%
-22.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 845 resolved cases

Office Action

§103
DETAILED ACTION Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 28 July 2026 has been entered. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Response to Amendment and Arguments Applicant’s request to update on record of the requested change of Applicant from ChampionX USA Inc. to ChampionX LLC under 37 CFR 1.46(c) has been processed. Applicant’s amendment does not distinguish from Bennett in view of Tiwari or Bennett in view of Meyer. Applicant’s arguments have been fully considered but are not persuasive. Applicant argues that Bennet fails to disclose from 5 wt.% to about 40 wt.% of the iron sulfide dissolver. The examiner disagrees. The examiner acknowledges that Bennett discloses that the amount of the "additional functional agent" other than listed component (a) through (p) will vary according to the particular composition being manufactured and its intended use ([0121]), however, such disclosure does not prevent one of ordinary skill in the art from estimating a range of the amount of the rest of the component based on the disclosed amount of components since the sum of all components will be 100%, , in the instant case, Bennet teaches the corrosion inhibiting component is present in an amount of preferably 15 wt.% ([0086]), the organic solvent component is present in an amount of 40 wt.% ([0103]), thus the amount of the gluconate would be less than 45 wt.% in the composition estimated by the examiner as the sum of all components of the composition will be 100%, which overlaps with the claimed range of claims 47 and 48 and encompasses the claimed range of claim 49. As to the function of the gluconate, the examiner maintains that Bennet teaches the presence of gluconate, which is the same compound as the claimed iron sulfide dissolver thus inherently capable of dissolving iron sulfide. Indeed, Bennet expressly discloses that the composition is particular useful for removal of deposit formed by hydrocarbon residual and iron sulfide ([0003] and [0020] and [0029]). As such the rejections over Bennett in view of Tiwari and over Bennett in view of Meyer stand. Claim Rejections - 35 USC § 103 Claims 40-51 and 53-59 stand rejected under 35 U.S.C. 103 as being unpatentable over Bennett in view of Tiwari. Bennet teaches a composition for removing oilfield hydrocarbon and iron sulfide based deposits and protection against corrosive fluids and gases comprises an imidazolinium based corrosion inhibitor ([0002], [0013] and [0056]), benzyl cocoalkyl(C12-C18)dimethylammonium chloride ([0120], which meets the claimed quaternary ammonium compound of formula(IV), an organic solvent such as ethanol, methanol, ethylene glycol etc. (0104]), a scale inhibitor ([0106]), and a synergistic agent such as 2-mercaptoethanol ([0102], which meets the claimed sulfur-containing compound. Bennet further teaches that the composition may further comprise a gluconate ([0115]), which meets the claimed iron sulfide dissolver, and alkali hydroxides such as sodium hydroxide ([0106], [0115] and [0118]), thus the presence of sodium gluconate. Bennet teaches the corrosion inhibiting component is present in an amount of preferably 15 wt.% ([0086]), which meets the claimed range, the organic solvent is present in an amount of 40 wt.% ([0103]), which meets claimed amount , thus the amount of the gluconate would be less than 45 wt.%, estimated by the examiner since the sum of all components of the composition will be 100%, thus a ratio corrosion inhibitor to gluconate is greater than 1:3 (i.e., 15%: <45%), which encompasses the claimed range of iron sulfide dissolver and the ratio of corrosion inhibitor to iron sulfide dissolver, respectively. One of ordinary skill in the art at the time the invention was made would have found it obvious to include the gluconate at the instantly claimed range thus the ratio of corrosion inhibitor to gluconate since it has been held that in the case where the claimed ranges “overlap or lie inside range disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 f. 2d 257,191 USPQ 90(CCPA 1976). See MPEP 2144.05.I. Generally, differences in ranges will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such ranges is critical. See MPEP 2144.05, In re Boesch, 617 F2d 272, 205 USPQ 215 (CCPA 1980); In re Aller, 220 F2d 454, 456, 105 USPQ 233, 235 (CCPA 1955) and In re Hoeschele, 406 F2d 1403, 160 USPQ 809 (CCPA 1969). Bennet does not teach the instantly claimed bis-quaternized imidazoline compound of formula (III). Tiwari teaches a bis-quaternized compound for inhibiting corrosion and/or removing hydrocarbonaceous deposits in oil and gas applications including refinery has the following general formula ( ([0001], [0011]-[0014], [0046],[0059] and formula (I)): PNG media_image1.png 148 332 media_image1.png Greyscale and exemplified as ([0037]): PNG media_image2.png 110 322 media_image2.png Greyscale Wherein RT is C17 alkyl ([0037]), which meets the claimed formula (III), wherein R1 and R2 are C17 alkyl, R3 and R4 are -C2H4-, x is 2, y is 1, nis 1, L1 and L2 are both -COOH. Tiwari further teaches that the compound can be mixed with other quaternary ammonium such as imidazolinium quaternary ammonium compound to provide superior corrosion inhibiting performance with low environment impact ([0010], [0055] and [0057]). At the time the invention was made it would have been obvious for a person of ordinary skill in the art to include the bis-quaternized corrosion inhibitor of Tiwari in the composition of Bennet. The rationale to do so would have been the motivation provided by the teachings of Tiwari that to do so would predictably provide superior corrosion inhibiting performance with low environment impact ([0010]). Claims 40-51 and 56-57 stand rejected under 35 U.S.C. 103 as being unpatentable over Bennett in view of Meyer. Bennet teaches a composition for removing oilfield hydrocarbon and iron sulfide based deposits and protection against corrosive fluids and gases including in refinery systems comprises an imidazolinium based corrosion inhibitor ([0002], [0013], [0029] and [0056]), benzyl cocoalkyl(C12-C18)dimethylammonium chloride ([0120], which meets the claimed quaternary ammonium compound of formula(IV), an organic solvent such as ethanol, methanol, ethylene glycol etc. (0104]), a scale inhibitor ([0106]), and a synergistic agent such as 2-mercaptoethanol ([0102], which meets the claimed sulfur-containing compound. Bennet further teaches that the composition may further comprise a gluconate ([0115]), which meets the claimed iron sulfide dissolver, and alkali hydroxides such as sodium hydroxide ([0106], [0115] and [0118]), thus the presence of sodium gluconate. Bennet teaches the corrosion inhibiting component is present in an amount of preferably 15 wt.% ([0086]), which meets the claimed range, the organic solvent is present in an amount of 40 wt.% ([0103]), which meets claimed amount , thus the amount of the gluconate would be less than 45 wt.%, estimated by the examiner since the sum of all components of the composition will be 100%, thus a ratio corrosion inhibitor to gluconate is greater than 1:3 (i.e, 15%: <45%), which encompasses the claimed range of iron sulfide dissolver and the ratio of corrosion inhibitor to iron sulfide dissolver, respectively. One of ordinary skill in the art at the time the invention was made would have found it obvious to include the gluconate at the instantly claimed range thus the ratio of corrosion inhibitor to gluconate since it has been held that in the case where the claimed ranges “overlap or lie inside range disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 f. 2d 257,191 USPQ 90(CCPA 1976). See MPEP 2144.05.I. Generally, differences in ranges will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such ranges is critical. See MPEP 2144.05, In re Boesch, 617 F2d 272, 205 USPQ 215 (CCPA 1980); In re Aller, 220 F2d 454, 456, 105 USPQ 233, 235 (CCPA 1955) and In re Hoeschele, 406 F2d 1403, 160 USPQ 809 (CCPA 1969). Bennet does not teach the instantly claimed bis-quaternized imidazoline compound of formula (III), wherein n is 0 and L2 is H. Meyer teaches a quaternized compound for inhibiting corrosion in oil and gas applications including refinery operations has the following general formula (col.11, line 60-65 and col.14,line 20-25): PNG media_image3.png 108 342 media_image3.png Greyscale Meyer further teaches that the compound can be mixed with other quaternary ammonium compound to provide superior corrosion inhibiting performance (col. 11, line 58-65, col.13,line 10-20 and col. 16, line 30-35). At the time the invention was made it would have been obvious for a person of ordinary skill in the art to include the quaternized corrosion inhibitor of Meyer in the composition of Bennet. The rationale to do so would have been the motivation provided by the teachings of Meyer that to do so would predictably provide superior corrosion inhibiting performance (col.11, line 58-65), and further since it has been held that it is prima facie obviousness to use a known material based on its suitability for its intended use, in the instant case, a corrosion inhibitor for oil gas applications and refinery operations. See MPEP 2144.06(II) and 2144.07; In re Fout, 675 F2d 297, 213 USPQ 532 (CCPA 1982); Sinclair & Carroll Co v Interchemical Corp, 325 US 327, 65 USPQ 297 (1945); In re Leshin, 227 F2d 197, 125 USPQ 416 (CCPA 1960) and Ryco, Inc v Ag-Bag Corp, 857 F2d 1418, 8 USPQ2d 1323 (Fed Cir 1988). Bennet further teaches that the composition can contain sulfonic acid ([0061] and [0080]), which renders the claimed bis-quaternized compound of formula(III) obvious wherein n is 0, L2 is H and R4 is C2 alkylene, as the acid of the composition protonates the tertiary imidazoline nitrogen. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AIQUN LI whose telephone number is (571)270-7736. The examiner can normally be reached Monday-Friday 9:00 am -4:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached at 571-2721302. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AIQUN LI/Ph.D., Primary Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

Show 10 earlier events
Jan 05, 2026
Request for Continued Examination
Jan 07, 2026
Response after Non-Final Action
Jan 12, 2026
Non-Final Rejection mailed — §103
Apr 03, 2026
Response Filed
Apr 28, 2026
Final Rejection mailed — §103
Jul 28, 2026
Request for Continued Examination
Aug 01, 2026
Response after Non-Final Action
Aug 13, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747383
SHALE HYDRATION INHIBITORS AND SUBTERRANEAN TREATMENT FLUIDS CONTAINING THEM
3y 2m to grant Granted Sep 29, 2026
Patent 12738480
NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY
3y 5m to grant Granted Sep 15, 2026
Patent 12719048
Method of Preparing Lithium Secondary Battery and Lithium Secondary Battery Prepared Thereby
3y 5m to grant Granted Aug 25, 2026
Patent 12712201
SOLID ELECTROLYTE AND ALL-SOLID-STATE BATTERY INCLUDING THE SAME
3y 5m to grant Granted Aug 18, 2026
Patent 12712183
NONAQUEOUS ELECTROLYTE SECONDARY BATTERY POSITIVE ELECTRODE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY
3y 3m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
64%
Grant Probability
87%
With Interview (+23.1%)
3y 0m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 845 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month